Explore the frontier
Filter every story, video, company, game and lab experiment by topic, disease area, technology, company, development stage, format and audience.
75 results
LongevityHepatocyte epigenetic reprogramming medicine
On June 2, 2026 NewLimit said it plans a first human trial of its liver reprogramming medicine in 2027 (company blog).
AI + MedicineOptive AI software for Swoop portable MRI
Hyperfine reported FDA clearance of next-generation Optive AI software in its Q2 2026 results on Aug. 6, 2026 (company release).
Cancer FrontiersGalleri multi-cancer early detection test
PMA submitted Jan. 29, 2026; an FDA advisory panel voted 7–2 (one abstention) on Sept. 23, 2026 that benefits outweigh risks, with a final FDA decision pending.
DeepTech + MedTechda Vinci 5 surgical system — cardiac indications
FDA 510(k) clearance for certain cardiac procedures announced Jan. 26, 2026 (company release).
Genome + CellsCTX112 (zugocabtagene geleucel)
As of the company's Aug. 3, 2026 update, CTX112 is in Phase 1 basket trials across several autoimmune diseases (company release).
Cancer FrontiersIntismeran autogene (V940 / mRNA-4157)
Phase 3 INTerpath-001 (NCT05933577) met its primary recurrence-free survival endpoint, announced Aug. 19, 2026; the companies say they will engage regulators on filings (company release).
Genome + CellsCasgevy (exagamglogene autotemcel)
FDA-approved Dec. 8, 2023 for sickle cell disease (age 12+); CRISPR Therapeutics reported on Aug. 3, 2026 that the FDA extended approval to children 2 years and older.
NewLimit
Not publicly tradedNewLimit develops epigenetic reprogramming medicines intended to restore youthful function to aged cells, starting with liver cells. It was co-founded by Brian…
Retro Biosciences
Not publicly tradedRetro Biosciences aims to extend healthy human lifespan through programs in autophagy, cell replacement and tissue reprogramming. Its lead oral drug, RTR242,…
Altos Labs
Not publicly tradedAltos Labs studies cellular rejuvenation — resetting aspects of cell state to restore health and resilience. It has research sites in the…
insitro
Not publicly tradedinsitro, founded by Daphne Koller, combines machine learning with human cellular data to identify disease drivers and design drug candidates. It has…
Hyperfine
Nasdaq: HYPRHyperfine makes the Swoop system, a portable, ultra-low-field MRI scanner for brain imaging at the point of care. The company was founded…